[ABO hemolytic disease of the newborn. Criteria for prognostic and therapeutic evaluation (except exsanguination transfusion)].
D000017:ABO Blood-Group System; D004899:Erythroblastosis, Fetal / Q000628:therapy*; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D010789:Phototherapy; D011247:Pregnancy; D012709:Serum Albumin / Q000627:therapeutic use
D000017:ABO Blood-Group System; D012709:Serum Albumin
La malattia emolitica neonatale da ABO. Criteri di valutazione prognostica e terapia (esclusa l'exsanguinotrasfusione)